1. Home
  2. NCPL vs VTAK Comparison

NCPL vs VTAK Comparison

Compare NCPL & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NCPL

Netcapital Inc.

HOLD

Current Price

$0.43

Market Cap

3.6M

Sector

Finance

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$0.98

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCPL
VTAK
Founded
1984
2002
Country
United States
United States
Employees
20
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
NCPL
VTAK
Price
$0.43
$0.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
148.7K
185.9K
Earning Date
03-19-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.53
EPS
N/A
N/A
Revenue
N/A
$442,000.00
Revenue This Year
$739.37
$1,170.33
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3057.14
52 Week Low
$0.31
$0.15
52 Week High
$8.75
$4.31

Technical Indicators

Market Signals
Indicator
NCPL
VTAK
Relative Strength Index (RSI) 49.13 42.78
Support Level $0.37 $0.15
Resistance Level $0.60 $1.28
Average True Range (ATR) 0.04 0.13
MACD 0.01 0.01
Stochastic Oscillator 70.38 42.79

Price Performance

Historical Comparison
NCPL
VTAK

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

Share on Social Networks: